Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tretinoin Cream 0.025% Bioequivalence in Acne Vulgaris
NCT04724473Phase 1Completed
- Start
- Dec 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tretinoin in acne vulgaris (3 arms). Primary endpoint: Demonstration of Bioequivalence at 12 weeks. Started Dec 2019; status: completed.
02
Drugs
tretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04724473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04724473.